Potential therapeutic interventions for fragile X syndrome
- 30 November 2010
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 16 (11), 516-527
- https://doi.org/10.1016/j.molmed.2010.08.005
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndromeBiochemical Pharmacology, 2010
- A Distinct DNA-Methylation Boundary in the 5′- Upstream Sequence of the FMR1 Promoter Binds Nuclear Proteins and Is Lost in Fragile X SyndromeAmerican Journal of Human Genetics, 2009
- FMR1: A gene with three facesBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndromeJournal of Neurodevelopmental Disorders, 2008
- Prepulse inhibition in fragile X syndrome: Feasibility, reliability, and implications for treatmentAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2008
- Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO miceNeurobiology of Disease, 2008
- Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation proteinNeuroscience Letters, 2007
- Psychopharmacology in fragile X syndrome—Present and futureMental Retardation and Developmental Disabilities Research Reviews, 2004
- Reduced Cortical Synaptic Plasticity and GluR1 Expression Associated with Fragile X Mental Retardation Protein DeficiencyMolecular and Cellular Neuroscience, 2002
- Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndromeCell, 1991